However, Connelly et al. suggested that inhibition of NF-κB might lead to the increased tumor latency and decreased tumor burden and numbers of lung metastases during breast cancer development in mice (Connelly et al., 2011). The gene discussed is NFKB1; the disease is neoplasm.